| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/07/2002 | US20020028765 Process for improving the growth of human head hair |
| 03/07/2002 | US20020028510 Cells for use in the treatment of nervous system disorders |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028254 Topically administering manganese and/or at least one organic and/or inorganic salt thereof. |
| 03/07/2002 | US20020028227 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 03/07/2002 | US20020028225 Prevents or reduces skin aging and skin drying by exhibiting superior effect on cell proliferation and synthesis of collagen and hyaluronic acid. |
| 03/07/2002 | US20020028218 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028190 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 03/07/2002 | DE10042064A1 Chinazoline, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Quinazolines, medicaments containing these compounds, their use and process for their preparation |
| 03/07/2002 | DE10042061A1 Bicyclische Heterocyclen,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10042060A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10042059A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10042058A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10041482A1 Substanzen zur Induktion und Intensivierung der Bräunungsmechanismen der Haut und kosmetische oder dermatologische Formulierungen dieselben enthaltend Substances for induction and intensification of the tanning mechanisms of the skin and cosmetic or dermatological formulations containing the same |
| 03/07/2002 | DE10041423A1 Biphenylderivate Biphenyl |
| 03/07/2002 | DE10040933A1 Verwendung von beta-Mannosylglycerat (Firoin) und/oder Derivaten, insbesondere dem beta-Mannosylglyceramid (Firoin-A), in kosmetischen und dermatologischen Formulierungen Use of beta-mannosylglycerate (firoin) and / or derivatives, in particular the beta-mannosylglyceramide (firoin-A), in cosmetic and dermatological formulations |
| 03/07/2002 | DE10040931A1 Verwendung von cyclischem 2,4 Diphosphoglycerat (cDGP) und/oder Derivaten in kosmetischen und dermatologischen Formulierungen The use of cyclic 2,4 diphosphoglycerate (CDGP) and / or derivatives in cosmetic and dermatological formulations |
| 03/07/2002 | CA2457162A1 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | CA2421893A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | CA2420667A1 Quinoline-(c=o)-(di-,tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2419841A1 Novel cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | CA2417042A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/06/2002 | EP1184384A1 1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives |
| 03/06/2002 | EP1184362A1 Phenol derivatives, process for preparation of the same and use thereof |
| 03/06/2002 | EP1184031A2 Foaming cosmetic cream for the treatment of fatty skins |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183351A1 Phospholipid transfer protein |
| 03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
| 03/06/2002 | EP1183333A1 Methods of using rnase p reaction mechanisms of action |
| 03/06/2002 | EP1183258A1 Imidazo-containing heterocyclic compounds, their compositions and uses |
| 03/06/2002 | EP1183256A1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/06/2002 | EP1183254A1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183074A1 Substituted biaryl ether compounds |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP1183037A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | EP1183007A1 Use of ascorbic acid and one or more flavone derivatives and/or flavan derivatives, especially flavonoids, for producing cosmetic or dermatological preparations used to prevent or sooth sunburns |
| 03/06/2002 | EP1182927A1 Antimicrobial sanitizing lotion with skin protection properties |
| 03/06/2002 | EP1096944B1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 03/06/2002 | EP0819122B1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 03/06/2002 | CN1339032A Reverse hydroxamate inhibitors of matrix metalloproteinases |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338922A Use of nanoscale chitosanes and/or chitosane derivatives |
| 03/06/2002 | CN1338300A Moistening ointment for treating burn and scald |
| 03/06/2002 | CN1338293A Prescription of Chinese medicine for treating leukodermia |
| 03/06/2002 | CN1338292A Liquid medicine for treating burn and scald |
| 03/06/2002 | CN1338290A Ointment for treating burn |
| 03/06/2002 | CN1338274A Powdered medicine 'Shaotangsan' for treating burn and scald |
| 03/06/2002 | CN1338272A Chinese medicine 'Lixiao Zhixue Zhitong Shengji Powder' |
| 03/06/2002 | CN1338270A Medicine for treating burn |
| 03/06/2002 | CN1338257A Cream for treating dermatopathy |
| 03/06/2002 | CN1080260C Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 03/05/2002 | US6353029 Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
| 03/05/2002 | US6353018 Compounds, their preparation and use |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 03/05/2002 | US6352985 Benzimidazole compounds |
| 03/05/2002 | US6352702 Antimicrobial composition |
| 03/05/2002 | US6352698 Free radical scavenger, antiallergen, and antiinflammatory agents |
| 03/05/2002 | US6352686 Antipsoriatic nail polish |
| 03/05/2002 | US6352685 External preparation for skin |
| 03/05/2002 | CA2356543A1 Process and composition for improving the growth of human head hair |
| 03/05/2002 | CA2049850C 4-substituted dihydropyrido[4,3-d]pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
| 02/28/2002 | WO2002016615A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016557A2 Tissue engineering scaffolds promoting matrix protein production |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002016370A1 1h-imidazopyridine derivatives |
| 02/28/2002 | WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | WO2002016352A1 Quinazoline derivatives |
| 02/28/2002 | WO2002016326A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 02/28/2002 | WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016313A2 Integrin receptor inhibitors |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2002015977A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | WO2002015936A1 Antifungal ketoconazole composition for topical use |
| 02/28/2002 | WO2002015923A1 Orally administered peptides to ameliorate atherosclerosis |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015917A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 02/28/2002 | WO2002015916A1 Use of dihydroboswellic acids or hydrogenated extracts of boswellia for prophylactic and/or therapeutic treatment |
| 02/28/2002 | WO2002015893A2 Treatment of wounds |
| 02/28/2002 | WO2002015892A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors |
| 02/28/2002 | WO2002015886A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |